Literature DB >> 34100114

Malignant salivary gland tumours in families with breast cancer susceptibility.

Carla B Ripamonti1, Paolo Bossi2, Siranoush Manoukian3, Laura Locati2, Mara Colombo4, Maria L Carcangiu5, Andrea Vingiani6, Lisa Licitra2,7, Paolo Radice4.   

Abstract

Salivary gland cancers (SGCs) are rare malignancies with highly heterogeneous histological features. Patients affected with SGCs are at increased risk of secondary malignancies, including breast cancer (BC). Previous studies enlightened a possible link between SGCs and hereditary predisposition to BC. Here, we searched for SGC-affected patients in 1796 high-risk BC families recruited at the Genetic Unit of the Istituto Nazionale dei Tumori of Milan, 516 of which carried pathogenic variants in BRCA1 and/or BRCA2, the main genetic risk factors for BC. We detected five families with an individual affected with SGC, including two male patients, one carrying a constitutional mutation in BRCA1 and the other in BRCA2. Loss of heterozygosity of BRCA wild-type alleles was assessed in the patients' tumour DNA. We conclude that our observations support the hypothesis that genetic factors associated with BC susceptibility might play a role also in at least a subset of SGCs.

Entities:  

Keywords:  BRCA1; BRCA2; Loss of heterozygosity; Salivary gland cancer

Year:  2021        PMID: 34100114     DOI: 10.1007/s00428-021-03105-6

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  12 in total

Review 1.  The morphological spectrum of salivary gland type tumours of the breast.

Authors:  Maria P Foschini; Luca Morandi; Sofia Asioli; Gianluca Giove; Angelo G Corradini; Vincenzo Eusebi
Journal:  Pathology       Date:  2016-12-30       Impact factor: 5.306

2.  Human epidermal growth factor receptor 2 (HER2) in salivary gland carcinomas.

Authors:  Till Sebastian Clauditz; Maren Reiff; Linn Gravert; Alexander Gnoss; Maria-Christina Tsourlakis; Adrian Münscher; Guido Sauter; Carsten Bokemeyer; Rainald Knecht; Waldemar Wilczak
Journal:  Pathology       Date:  2011-08       Impact factor: 5.306

3.  Salivary gland cancer in BRCA-positive families: a retrospective review.

Authors:  Tim K Shen; Theodoros N Teknos; Amanda E Toland; Leigha Senter; Rebecca Nagy
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2014-12       Impact factor: 6.223

4.  The repertoire of genetic alterations in salivary duct carcinoma including a novel HNRNPH3-ALK rearrangement.

Authors:  Snjezana Dogan; Charlotte K Y Ng; Bin Xu; Rahul Kumar; Lu Wang; Marcia Edelweiss; Sasinya N Scott; Ahmet Zehir; Alexander Drilon; Luc G T Morris; Nancy Y Lee; Cristina R Antonescu; Alan L Ho; Nora Katabi; Michael F Berger; Jorge S Reis-Filho
Journal:  Hum Pathol       Date:  2019-04-01       Impact factor: 3.466

5.  Epidemiology of rare cancers and inequalities in oncologic outcomes.

Authors:  G Gatta; A Trama; R Capocaccia
Journal:  Eur J Surg Oncol       Date:  2017-09-19       Impact factor: 4.424

6.  Risk of Development of Second Primary Head and Neck Cancer following an Index Breast Cancer.

Authors:  Jessica Yesensky; Alexandra Kyrillos; Kristine Kuchta; Katharine Yao; Chi-Hsiung Wang; Mihir K Bhayani
Journal:  Otolaryngol Head Neck Surg       Date:  2017-10-17       Impact factor: 3.497

7.  Increased risk of breast cancer development after diagnosis of salivary gland tumour.

Authors:  Caroline D In der Maur; Willem J Klokman; Floor E van Leeuwen; I Bing Tan; Emiel J Th Rutgers; Alfons J M Balm
Journal:  Eur J Cancer       Date:  2005-06       Impact factor: 9.162

8.  Comprehensive genomic profiling of salivary mucoepidermoid carcinomas reveals frequent BAP1, PIK3CA, and other actionable genomic alterations.

Authors:  K Wang; J D McDermott; A B Schrock; J A Elvin; L Gay; S D Karam; D Raben; H Somerset; S M Ali; J S Ross; D W Bowles
Journal:  Ann Oncol       Date:  2017-04-01       Impact factor: 32.976

9.  Mutation detection rates associated with specific selection criteria for BRCA1/2 testing in 1854 high-risk families: A monocentric Italian study.

Authors:  Jacopo Azzollini; Giulietta Scuvera; Eleonora Bruno; Patrizia Pasanisi; Daniela Zaffaroni; Mariarosaria Calvello; Barbara Pasini; Carla B Ripamonti; Mara Colombo; Valeria Pensotti; Paolo Radice; Bernard Peissel; Siranoush Manoukian
Journal:  Eur J Intern Med       Date:  2016-04-06       Impact factor: 4.487

10.  Profiling of 149 Salivary Duct Carcinomas, Carcinoma Ex Pleomorphic Adenomas, and Adenocarcinomas, Not Otherwise Specified Reveals Actionable Genomic Alterations.

Authors:  Kai Wang; Jeffery S Russell; Jessica D McDermott; Julia A Elvin; Depinder Khaira; Adrienne Johnson; Timothy A Jennings; Siraj M Ali; Molly Murray; Carrie Marshall; Dwight S Oldham; Donna Washburn; Stuart J Wong; Juliann Chmielecki; Roman Yelensky; Doron Lipson; Vincent A Miller; Philip J Stephens; Hilary S Serracino; Jeffrey S Ross; Daniel W Bowles
Journal:  Clin Cancer Res       Date:  2016-06-22       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.